(Q37587778)

21 August 2017

1 reference

title

Exacerbation of inflammatory bowel diseases associated with the use of nonsteroidal anti-inflammatory drugs: myth or reality? (English)

1 reference

inflammatory bowel diseases

21 August 2017

main subject

0 references

inflammation

0 references

author name string

Helenie Kefalakes

1

1 reference

21 August 2017

Theodoros J Stylianides

2

1 reference

21 August 2017

George Amanakis

3

1 reference

21 August 2017

George Kolios

4

1 reference

21 August 2017

publication date

27 August 2009

1 reference

European Journal of Clinical Pharmacology

21 August 2017

published in

1 reference

21 August 2017

volume

65

1 reference

21 August 2017

issue

10

1 reference

21 August 2017

page(s)

963-970

1 reference

https://scigraph.springernature.com/pub.10.1007/s00228-009-0719-3

21 August 2017

exact match

0 references

cites work

Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use.

2 references

https://api.crossref.org/works/10.1007%2FS00228-009-0719-3

21 January 2018

12 December 2020

Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0719-3

Exacerbation of inflammatory bowel disease by nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors: fact or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0719-3

Prostaglandin E2, prostaglandin I2 and the vascular changes of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0719-3

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0719-3

Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease

21 January 2018

1 reference

12 December 2020

Clinical and endoscopic features of nonsteroidal anti-inflammatory drug-induced colonic ulcerations

1 reference

12 December 2020

Mechanisms underlying intestinal injury induced by anti-inflammatory COX inhibitors

1 reference

12 December 2020

Inflammatory Bowel Disease

1 reference

12 December 2020

Relapse of ulcerative proctocolitis during treatment with non-steroidal anti-inflammatory drugs

1 reference

12 December 2020

Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration.

1 reference

12 December 2020

Inhibition of both COX-1 and COX-2 and resulting decrease in the level of prostaglandins E2 is responsible for non-steroidal anti-inflammatory drug (NSAID)-dependent exacerbation of colitis

1 reference

12 December 2020

Use of NSAIDs, COX-2 inhibitors, and acetaminophen and associated coprescriptions of gastroprotective agents in an elderly population

1 reference

12 December 2020

Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study

1 reference

12 December 2020

Chemoprevention for colon cancer: new opportunities, fact or fiction?

1 reference

12 December 2020

Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease

1 reference

12 December 2020

Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial

1 reference

12 December 2020

The gastrointestinal safety and effect on disease activity of etoricoxib, a selective cox-2 inhibitor in inflammatory bowel diseases

1 reference

12 December 2020

Mitochondrial damage: a possible mechanism of the "topical" phase of NSAID induced injury to the rat intestine

1 reference

12 December 2020

Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease

1 reference

12 December 2020

Cyclooxygenase in biology and disease

1 reference

12 December 2020

Selective use of selective nonsteroidal anti-inflammatory drugs in inflammatory bowel disease

1 reference

12 December 2020

Therapy of spondylarthropathy in inflammatory bowel disease.

1 reference

12 December 2020

COX-1 and COX-2 products in the gut: therapeutic impact of COX-2 inhibitors

1 reference

12 December 2020

Rofecoxib and inflammatory bowel disease: clinical and pathologic observations

1 reference

12 December 2020

Role of endogenous prostaglandins in preventing gastrointestinal ulceration: induction of ulcers by antibodies to prostaglandins.

1 reference

12 December 2020

Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2.

1 reference

12 December 2020

A simple method for assessing intestinal inflammation in Crohn's disease

1 reference

12 December 2020

Safety of celecoxib in patients with ulcerative colitis in remission: a randomized, placebo-controlled, pilot study

1 reference

12 December 2020

Nonsteroidal antiinflammatory drugs and the small intestine

1 reference

12 December 2020

Healing impairment effect of cyclooxygenase inhibitors on dextran sulfate sodium-induced colitis in rats

1 reference

12 December 2020

Introduction to eicosanoids and the gastroenteric tract

1 reference

12 December 2020

Prostaglandins, NSAIDs, and Gastric Mucosal Protection: Why Doesn't the Stomach Digest Itself?

1 reference

12 December 2020

Comparison of indomethacin and nimesulide, a selective cyclooxygenase-2 inhibitor, on key pathophysiologic steps in the pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in the rat

1 reference

12 December 2020

Exacerbation of Crohn's colitis with severe colonic hemorrhage in a patient on rofecoxib

1 reference

12 December 2020

Epidemiology and differential diagnosis of NSAID-induced injury to the mucosa of the small intestine

1 reference

12 December 2020

Cyclooxygenase expression in intestinal epithelial cells

1 reference

12 December 2020

An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drugs in patients with inflammatory bowel disease

1 reference

12 December 2020

Do NSAIDs, antibiotics, infections, or stress trigger flares in IBD?

1 reference

12 December 2020

Drug enterocyte adducts: possible causal factor for diclofenac enteropathy in rats

1 reference

12 December 2020

Prostaglandin biology in inflammatory bowel disease

1 reference

12 December 2020

Toxic effects of nonsteroidal antiinflammatory drugs on the small bowel, colon, and rectum

1 reference

12 December 2020

Exacerbation of inflammatory bowel disease associated with use of celecoxib

1 reference

12 December 2020

Rofecoxib and cytomegalovirus in acute flare-up of ulcerative colitis: coprecipitants or coincidence?

1 reference

12 December 2020

Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.

1 reference

12 December 2020

Cyclooxygenase-1 and Cyclooxygenase-2 Selectivity of Widely Used Nonsteroidal Anti-Inflammatory Drugs

1 reference

12 December 2020

The effects of aspirin on gastric mucosal integrity, surface hydrophobicity, and prostaglandin metabolism in cyclooxygenase knockout mice

1 reference

12 December 2020

Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen

1 reference

12 December 2020

Selective COX-2 inhibitors and human inflammatory bowel disease

1 reference

12 December 2020

COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: a double blind crossover study comparing rofecoxib with placebo and indomethacin

1 reference

12 December 2020

Clinical, endoscopic, and histologic spectrum of nonsteroidal anti-inflammatory drug-induced lesions in the colon.

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drug-induced small-bowel lesions identified by double-balloon endoscopy: endoscopic features of the lesions and endoscopic treatments for diaphragm disease

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drug gastropathy

1 reference

12 December 2020

Regulatory role of phosphatidylinositol 3-kinase on TNF-alpha-induced cyclooxygenase 2 expression in colonic epithelial cells.

1 reference

12 December 2020

Protective effect of metronidazole on uncoupling mitochondrial oxidative phosphorylation induced by NSAID: a new mechanism

1 reference

12 December 2020

Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans

1 reference

12 December 2020

Expression of cyclooxygenase-2 mRNA in active inflammatory bowel disease

1 reference

12 December 2020

Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drugs and lower gastrointestinal complications

1 reference

12 December 2020

Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drugs and inflammatory bowel disease: current perspectives

1 reference

12 December 2020

Profile and mechanisms of gastrointestinal and other side effects of nonsteroidal anti-inflammatory drugs (NSAIDs).

1 reference

12 December 2020

Tolerance of nonsteroidal antiinflammatory drugs in patients with inflammatory bowel disease

1 reference

12 December 2020

NSAID-induced gastric damage in rats: Requirement for inhibition of both cyclooxygenase 1 and 2

1 reference

12 December 2020

Intestinal permeability in the pathogenesis of NSAID-induced enteropathy

1 reference

12 December 2020

A long-term cohort study of nonsteroidal anti-inflammatory drug use and disease activity in outpatients with inflammatory bowel disease

1 reference

12 December 2020

Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans.

1 reference

12 December 2020

Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem.

1 reference

12 December 2020

Clinical pharmacokinetics of meloxicam. A cyclo-oxygenase-2 preferential nonsteroidal anti-inflammatory drug

1 reference

12 December 2020

Relapse of inflammatory bowel disease associated with use of nonsteroidal anti-inflammatory drugs

1 reference

12 December 2020

Lack of beneficial effect of COX-2 inhibitors in an experimental model of colitis

1 reference

12 December 2020

10.1007/S00228-009-0719-3

Identifiers

DOI

1 reference

21 August 2017

1 reference